OBJECTIVE: The FDA has not approved the use of testosterone in women. However, parenteral testosterone is being used off-label in free standing clinics throughout America. The recent multi-ethnic study of atherosclerosis (MESA) population study showed that postmenopausal women with a higher testosterone/estradiol ratio had a higher incident of cardiovascular disease. This is a case of a postmenopausal woman who dissected her thoracic aorta after 8 months of parenteral testosterone. METHODS: The clinical examination, radiographic, and laboratory findings of a patient are presented along with a review of the literature. RESULTS: A heathy postmenopausal women, whose only risk factor was parenteral testosterone, developed a dissection of her entire thoracic aorta. CONCLUSION: The MESA study and other conflicting publications on cardiovascular events in transgender patients receiving exogenous androgens indicates the need for further investigation to determine the safety of testosterone therapy for women and its possible role in contributing to aortic disease.
OBJECTIVE: The FDA has not approved the use of testosterone in women. However, parenteral testosterone is being used off-label in free standing clinics throughout America. The recent multi-ethnic study of atherosclerosis (MESA) population study showed that postmenopausal women with a higher testosterone/estradiol ratio had a higher incident of cardiovascular disease. This is a case of a postmenopausal woman who dissected her thoracic aorta after 8 months of parenteral testosterone. METHODS: The clinical examination, radiographic, and laboratory findings of a patient are presented along with a review of the literature. RESULTS: A heathy postmenopausal women, whose only risk factor was parenteral testosterone, developed a dissection of her entire thoracic aorta. CONCLUSION: The MESA study and other conflicting publications on cardiovascular events in transgender patients receiving exogenous androgens indicates the need for further investigation to determine the safety of testosterone therapy for women and its possible role in contributing to aortic disease.
Authors: Di Zhao; Eliseo Guallar; Pamela Ouyang; Vinita Subramanya; Dhananjay Vaidya; Chiadi E Ndumele; Joao A Lima; Matthew A Allison; Sanjiv J Shah; Alain G Bertoni; Matthew J Budoff; Wendy S Post; Erin D Michos Journal: J Am Coll Cardiol Date: 2018-06-05 Impact factor: 24.094
Authors: Nienke M Nota; Chantal M Wiepjes; Christel J M de Blok; Louis J G Gooren; Baudewijntje P C Kreukels; Martin den Heijer Journal: Circulation Date: 2019-03-12 Impact factor: 29.690
Authors: Yasir Alsiraj; Sean E Thatcher; Richard Charnigo; Kuey Chen; Eric Blalock; Alan Daugherty; Lisa A Cassis Journal: Circulation Date: 2016-11-04 Impact factor: 29.690
Authors: Darios Getahun; Rebecca Nash; W Dana Flanders; Tisha C Baird; Tracy A Becerra-Culqui; Lee Cromwell; Enid Hunkeler; Timothy L Lash; Andrea Millman; Virginia P Quinn; Brandi Robinson; Douglas Roblin; Michael J Silverberg; Joshua Safer; Jennifer Slovis; Vin Tangpricha; Michael Goodman Journal: Ann Intern Med Date: 2018-07-10 Impact factor: 25.391
Authors: Tracy Henriques; Xuan Zhang; Frederique B Yiannikouris; Alan Daugherty; Lisa A Cassis Journal: Arterioscler Thromb Vasc Biol Date: 2008-05-01 Impact factor: 8.311
Authors: Christoph A Nienaber; Rossella Fattori; Rajendra H Mehta; Barbara M Richartz; Arturo Evangelista; Michael Petzsch; Jeanna V Cooper; James L Januzzi; Hüseyin Ince; Udo Sechtem; Eduardo Bossone; Jianming Fang; Dean E Smith; Eric M Isselbacher; Linda A Pape; Kim A Eagle Journal: Circulation Date: 2004-06-14 Impact factor: 29.690
Authors: John P Davis; Morgan Salmon; Nicolas H Pope; Guanyi Lu; Gang Su; Akshaya Meher; Gorav Ailawadi; Gilbert R Upchurch Journal: J Vasc Surg Date: 2016-01-24 Impact factor: 4.268
Authors: Frank A Lederle; Joseph C Larson; Karen L Margolis; Matthew A Allison; Matthew S Freiberg; Barbara B Cochrane; William F Graettinger; J David Curb Journal: BMJ Date: 2008-10-14